stoxline Quote Chart Rank Option Currency Glossary
  
908 Devices Inc. (MASS)
2.64  -0.01 (-0.38%)    02-06 10:02
Open: 2.66
High: 2.671
Volume: 30,553
  
Pre. Close: 2.65
Low: 2.56
Market Cap: 92(M)
Technical analysis
2025-02-06 9:48:43 AM
Short term     
Mid term     
Targets 6-month :  3.25 1-year :  3.84
Resists First :  2.78 Second :  3.28
Pivot price 2.62
Supports First :  1.96 Second :  1.63
MAs MA(5) :  2.48 MA(20) :  2.53
MA(100) :  2.86 MA(250) :  4.61
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  33.3 D(3) :  31.9
RSI RSI(14): 53
52-week High :  7.9 Low :  1.8
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ MASS ] has closed above bottom band by 46.6%. Bollinger Bands are 1.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.69 - 2.7 2.7 - 2.71
Low: 2.32 - 2.33 2.33 - 2.35
Close: 2.63 - 2.65 2.65 - 2.67
Company Description

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Headline News

Wed, 05 Feb 2025
908 devices CEO Kevin J. Knopp sells $37,109 in stock - MSN

Tue, 04 Feb 2025
908 Devices' chief product officer sells $18,190 in stock - Investing.com

Thu, 30 Jan 2025
Vanguard Group Inc Reduces Stake in 908 Devices Inc - GuruFocus.com

Thu, 23 Jan 2025
Q4 EPS Estimates for 908 Devices Reduced by Leerink Partnrs - MarketBeat

Tue, 14 Jan 2025
908 Devices Hits Record Q4 Revenue with 20% Growth, RedWave Acquisition Delivers Strong Results - StockTitan

Tue, 14 Jan 2025
908 Devices Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results - Business Wire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 35 (M)
Shares Float 26 (M)
Held by Insiders 8.1 (%)
Held by Institutions 69.7 (%)
Shares Short 1,920 (K)
Shares Short P.Month 1,420 (K)
Stock Financials
EPS -1.79
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 3.77
Profit Margin -109.2 %
Operating Margin -70.6 %
Return on Assets (ttm) -15.6 %
Return on Equity (ttm) -40 %
Qtrly Rev. Growth 17.2 %
Gross Profit (p.s.) 0.8
Sales Per Share 1.58
EBITDA (p.s.) -1.28
Qtrly Earnings Growth 0 %
Operating Cash Flow -30 (M)
Levered Free Cash Flow -18 (M)
Stock Valuations
PE Ratio -1.46
PEG Ratio 0
Price to Book value 0.68
Price to Sales 1.64
Price to Cash Flow -3.03
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android